{"id":"F2007B00633","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 6 of 2004)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-2004","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62426,"registerId":"commonwealth-F2007B00633-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 6 of 2004)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 6 of 2004\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 May 2004.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nCefotetan Disodium\n\nNefazodone Hydrochloride\n\nOestrogens—Conjugated and Medroxyprogesterone Acetate\n\nDated this sixth day of April 2004.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1688},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This declaration performs exactly the function authorised by subsection 85(2AA) of the National Health Act 1953: removing specific pharmaceutical benefits from the PBS. It has not expanded beyond this specific administrative purpose of delisting three named drugs."},"complexity_factors":["Single operational clause with straightforward legal effect","Minimal cross-referencing (only cites enabling sections 85(2AA) and 85(2AB))","Short schedule containing only three specific drug entries","No defined terms, exceptions, or conditional logic"],"plain_english_summary":"This declaration removes government subsidies for three prescription medicines from Australia’s Pharmaceutical Benefits Scheme (PBS) from 1 May 2004. Cefotetan disodium, nefazodone hydrochloride, and conjugated oestrogens with medroxyprogesterone acetate will no longer be sold at PBS prices, so patients must pay full commercial costs or seek alternatives; the decision was made by the Health delegate after PBAC advice."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-2004","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-2004/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-2004/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-2004/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-2004/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-6-of-2004/documents"}}